AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Sitapride-M 100/500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Micro Labs Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitapride-M 100/500 Tablet SR

Diabetace Duo 100/500mg Extended-Release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like nephropathy and vision loss, potentially lessening the risk of cardiovascular events. Diabetace Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel. Interactions with other medications are possible; disclose all current medications to ensure safe use. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Uses of Sitapride-M 100/500 Tablet SR

Managing type 2 diabetes

Major Benefits of Sitapride-M 100/500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitapride-M 100/500 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Sitapride-M 100/500 Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapride-M 100/500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitapride-M 100/500 Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitapride-M 100/500 Tablet SR works:

Sitagliptin and metformin, combined in Sitapride-M 100/500 SR tablets, offer enhanced blood glucose management. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, acts by reducing liver glucose production, slowing intestinal glucose absorption, and increasing insulin sensitivity. This dual-action approach leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitapride-M 100/500 Tablet SR is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitapride-M 100/500 SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sitapride-M 100/500mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitapride-M 100/500 SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Using Sitapride-M 100/500 SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitapride-M 100/500 Tablet SR :

Should you forget a dose of Sitapride-M 100/500 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Sitapride-M 100/500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitapride-M 100/500 Tablet SR

Sitapride-M 100/500 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitapride-M 100/500 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia), if left unaddressed. Preventive yearly supplemental vitamin B12 is recommended by some researchers.
Sitapride-M 100/500 Tablet SR may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 100/500 Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitapride-M 100/500 Tablet SR with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 100/500 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitapride-M 100/500 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitapride-M 100/500 Tablet SR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Sitapride-M 100/500 Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapride-M 100/500 Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitapride-M 100/500 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitapride-M 100/500 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive measures, suggested by some researchers, include annual supplemental vitamin B12 intake.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 100/500 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitapride-M 100/500 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitapride-M 100/500 Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitapride-M 100/500 Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitapride-M 100/500 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitapride-M 100/500 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 100/500 Table...
167
MRP 194
13% off